Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Thyroid Cancer Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Papillary Carcinoma, Follicular Carcinoma, Others)
5.2.2. By Technique (Blood Test, Imaging, Biopsy, Others)
5.2.3. By End-use (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Product Market Map
5.3.1. By Type
5.3.2. By Technique
5.3.3. By End-use
5.3.4. By Region
6. North America Thyroid Cancer Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Papillary Carcinoma, Follicular Carcinoma, Others)
6.2.2. By Technique (Blood Test, Imaging, Biopsy, Others)
6.2.3. By End-use (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Thyroid Cancer Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Technique
6.3.1.2.3. By End-use
6.3.2. Canada Thyroid Cancer Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Technique
6.3.2.2.3. By End-use
6.3.3. Mexico Thyroid Cancer Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Technique
6.3.3.2.3. By End-use
7. Europe Thyroid Cancer Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Papillary Carcinoma, Follicular Carcinoma, Others)
7.2.2. By Technique (Blood Test, Imaging, Biopsy, Others)
7.2.3. By End-use (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Thyroid Cancer Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Technique
7.3.1.2.3. By End-use
7.3.2. United Kingdom Thyroid Cancer Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Technique
7.3.2.2.3. By End-use
7.3.3. France Thyroid Cancer Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Technique
7.3.3.2.3. By End-use
7.3.4. Italy Thyroid Cancer Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Technique
7.3.4.2.3. By End-use
7.3.5. Spain Thyroid Cancer Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Technique
7.3.5.2.3. By End-use
8. Asia-Pacific Thyroid Cancer Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Papillary Carcinoma, Follicular Carcinoma, Others)
8.2.2. By Technique (Blood Test, Imaging, Biopsy, Others)
8.2.3. By End-use (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Thyroid Cancer Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Technique
8.3.1.2.3. By End-use
8.3.2. Japan Thyroid Cancer Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Technique
8.3.2.2.3. By End-use
8.3.3. India Thyroid Cancer Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Technique
8.3.3.2.3. By End-use
8.3.4. Australia Thyroid Cancer Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Technique
8.3.4.2.3. By End-use
8.3.5. South Korea Thyroid Cancer Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Technique
8.3.5.2.3. By End-use
9. South America Thyroid Cancer Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Papillary Carcinoma, Follicular Carcinoma, Others)
9.2.2. By Technique (Blood Test, Imaging, Biopsy, Others)
9.2.3. By End-use (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Thyroid Cancer Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Technique
9.3.1.2.3. By End-use
9.3.2. Argentina Thyroid Cancer Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Technique
9.3.2.2.3. By End-use
9.3.3. Colombia Thyroid Cancer Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Technique
9.3.3.2.3. By End-use
10. Middle East and Africa Thyroid Cancer Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Papillary Carcinoma, Follicular Carcinoma, Others)
10.2.2. By Technique (Blood Test, Imaging, Biopsy, Others)
10.2.3. By End-use (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Thyroid Cancer Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Technique
10.3.1.2.3. By End-use
10.3.2. Saudi Arabia Thyroid Cancer Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Technique
10.3.2.2.3. By End-use
10.3.3. UAE Thyroid Cancer Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Technique
10.3.3.2.3. By End-use
10.3.4. Kuwait Thyroid Cancer Diagnostics Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Type
10.3.4.2.2. By Technique
10.3.4.2.3. By End-use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porter?s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
14.6.1. F Hoffmann-La Roche AG
14.6.2. Abbott Laboratories Inc
14.6.3. Thermo Fisher Scientific Inc
14.6.4. General Electric Co
14.6.5. Siemens Healthcare GmbH
14.6.6. Bio-Rad Laboratories Inc
14.6.7. Toshiba Corporation
14.6.8. Koninklijke Philips NV
14.6.9. Agilent Technologies Inc
15. Strategic Recommendations
16. About Us & Disclaimer